Dinesh Khanna Selected Research

Mycophenolic Acid (Cellcept)

6/2021	A Case of Recalcitrant Linear Morphea Responding to Subcutaneous Abatacept.
1/2021	Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
6/2020	Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II.
1/2020	Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.
11/2018	Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
4/2017	Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.
1/2017	Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.
9/2016	Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.
1/2016	Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dinesh Khanna Research Topics

Disease

102	Systemic Scleroderma (Systemic Sclerosis) 05/2024 - 02/2005
48	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024 - 02/2005
43	Fibrosis (Cirrhosis) 03/2024 - 04/2009
26	Rheumatoid Arthritis 01/2016 - 01/2004
23	Diffuse Scleroderma (Progressive Systemic Sclerosis) 03/2024 - 01/2007
19	Gout 01/2021 - 03/2010
15	Pulmonary Arterial Hypertension 10/2022 - 11/2013
12	Dyspnea (Shortness of Breath) 01/2019 - 02/2005
11	Inflammation (Inflammations) 01/2023 - 06/2007
9	Skin Diseases (Skin Disease) 02/2024 - 08/2003
9	digital ulcers 12/2023 - 10/2009
8	Fatigue 04/2024 - 12/2008
7	Arthritis (Polyarthritis) 01/2019 - 08/2003
6	Pain (Aches) 04/2024 - 02/2009
6	Chronic Disease (Chronic Diseases) 04/2024 - 06/2007
6	Disease Progression 01/2024 - 01/2018
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2023 - 03/2012
6	Connective Tissue Diseases (Connective Tissue Disease) 01/2023 - 12/2013
6	Contracture 11/2018 - 06/2010
6	Pulmonary Hypertension 09/2017 - 05/2007
5	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 09/2005
5	Lung Diseases (Lung Disease) 06/2020 - 05/2007
4	Sclerosis 01/2022 - 04/2009
4	Infections 12/2020 - 06/2016
4	Telangiectasis (Telangiectasia) 06/2014 - 03/2012
3	Ulcer 12/2023 - 03/2012
3	Gastroesophageal Reflux (GERD) 01/2023 - 03/2012
3	Headache (Headaches) 01/2023 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 09/2005
3	Calcinosis 10/2020 - 03/2012
3	Anemia 01/2019 - 01/2014
3	Heart Failure 01/2017 - 01/2004
3	Rheumatic Diseases (Rheumatism) 01/2016 - 09/2005
2	Localized Scleroderma (Morphea) 10/2023 - 06/2021
2	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2023 - 04/2016
2	Diarrhea 01/2023 - 05/2016
2	Cough 11/2022 - 04/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 04/2019
2	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2004
2	Chronic Renal Insufficiency 01/2020 - 01/2020
2	Idiopathic Pulmonary Fibrosis 01/2020 - 01/2019
2	Cytopenia 01/2019 - 02/2010

Drug/Important Bio-Agent (IBA)

22	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 02/2005
20	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2009
15	ametantrone (HAQ)IBA 01/2017 - 05/2005
13	Carbon MonoxideIBA 12/2021 - 02/2005
13	Uric Acid (Urate)IBA 01/2021 - 03/2010
12	tocilizumab (atlizumab)FDA Link 06/2023 - 06/2016
9	AutoantibodiesIBA 01/2023 - 11/2013
9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2021 - 01/2016
8	nintedanibIBA 06/2023 - 01/2021
8	Antirheumatic Agents (DMARD)IBA 03/2020 - 08/2003
7	Abatacept (Orencia)FDA Link 01/2023 - 01/2016
7	Methotrexate (Mexate)FDA LinkGeneric 06/2021 - 10/2005
7	Febuxostat FDA Link 01/2020 - 03/2014
6	riociguatIBA 03/2024 - 01/2017
6	CytokinesIBA 01/2023 - 01/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009 - 01/2004
5	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 08/2003
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2018
5	Rituximab (Mabthera)FDA Link 01/2023 - 01/2010
5	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 07/2011
4	Interleukin-6 (Interleukin 6)IBA 11/2023 - 04/2014
4	anti-scl-70 autoantibodiesIBA 06/2023 - 03/2012
4	C-Reactive ProteinIBA 01/2023 - 06/2005
4	CollagenIBA 01/2023 - 01/2014
4	Bleomycin (Blenoxane)FDA LinkGeneric 04/2019 - 01/2017
4	Certolizumab Pegol FDA Link 07/2012 - 05/2010
3	EnzymesIBA 03/2024 - 06/2007
3	AntibodiesIBA 02/2024 - 06/2014
3	Monoclonal AntibodiesIBA 06/2023 - 11/2006
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2018
3	GlucocorticoidsIBA 06/2021 - 01/2020
3	Pegloticase FDA Link 01/2021 - 07/2012
3	Antinuclear AntibodiesIBA 01/2021 - 03/2012
3	Colchicine FDA LinkGeneric 01/2020 - 08/2014
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 12/2013
3	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 11/2011
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 11/2011
3	Etanercept (Enbrel)FDA Link 07/2007 - 07/2003
2	Transcription Factors (Transcription Factor)IBA 05/2024 - 06/2014
2	ChromatinIBA 05/2024 - 01/2021
2	Messenger RNA (mRNA)IBA 03/2024 - 10/2021
2	ImmunosorbentsIBA 03/2024 - 04/2020
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2024 - 12/2017
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2023 - 06/2016
2	lysophosphatidic acidIBA 01/2023 - 10/2018
2	RNA Polymerase IIIIBA 01/2023 - 03/2012
2	lenabasum (ajulemic acid)IBA 01/2023 - 07/2021
2	InterferonsIBA 11/2022 - 01/2021
2	Iloprost (Ventavis)FDA Link 01/2021 - 02/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2017
2	CalciumIBA 10/2020 - 04/2008

Therapy/Procedure

63	Therapeutics 04/2024 - 04/2004
3	Ambulatory Care (Outpatient Care) 01/2017 - 12/2008
2	Activities of Daily Living (ADL) 10/2023 - 10/2009
2	Total Parenteral Nutrition 01/2023 - 04/2016
2	Precision Medicine 12/2022 - 06/2021
2	Occupational Therapy (Therapy, Occupational) 11/2021 - 11/2018